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Simple Summary: New technologies allow researchers to improve the methods for immediate,
accurate data collection, cleaning and analysis, with minimal geographical limitations. Although
much has improved in the field of equine anaesthesia in recent years, we are still far from reducing
anaesthetic-related mortality in this species in comparison with small animal anaesthesia. The aim
of this multicentre study was to probe the usefulness of an internet-based method that utilised an
electronic questionnaire and statistical software to show the data and report outcomes from horses
undergoing general anaesthesia and certain procedures using standing sedation. Within six months,
8656 cases from 69 centres were collected: 6701 procedures under general anaesthesia and 1955
under standing sedation. The results demonstrated (i) the utility of the method and (ii) that some
horses died unexpectedly when undergoing not only general anaesthesia, but also standing sedation.
Finally, (iii) we present some descriptive data that outline the current anaesthesia practice compared
with the previous CEPEF2. We concluded that our internet-based method is suitable for this type of
study. New techniques may reduce the mortality rate. However, the results presented here should be
interpreted cautiously as these are only preliminary data with lower numbers than CEPEF2.
Abstract: It is almost 20 years since the largest observational, multicentre study evaluating the risks of
mortality associated with general anaesthesia in horses. We proposed an internet-based method to collect
data (cleaned and analysed with R) in a multicentre, cohort, observational, analytical, longitudinal and
prospective study to evaluate peri-operative equine mortality. The objective was to report the usefulness
of the method, illustrated with the preliminary data, including outcomes for horses seven days after
undergoing general anaesthesia and certain procedures using standing sedation. Within six months,
data from 6701 procedures under general anaesthesia and 1955 standing sedations from 69 centres were
collected. The results showed (i) the utility of the method; also, that (ii) the overall mortality rate for
general anaesthesia within the seven-day outcome period was 1.0%. In horses undergoing procedures
other than exploratory laparotomy for colic (“noncolics”), the rate was lower, 0.6%, and in “colics” it was
higher, at 3.4%. For standing sedations, the overall mortality rate was 0.2%. Finally, (iii) we present
some descriptive data that demonstrate new developments since the previous CEPEF2. In conclusion,
horses clearly still die unexpectedly when undergoing procedures under general anaesthesia or standing
sedation. Our method is suitable for case collection for future studies.
Keywords: anaesthesia; CEPEF; data analysis; death; epidemiology; equine; horse; mortality; stand-
ing sedation
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1. Introduction
Internet-based research has become commonplace during the last 10–20 years and
makes online data collection possible from a large pool of participants with few geograph-
ical limitations. Online data collection is quick, cheap and increases the accuracy and
efficacy of data entry [1]. Moreover, data can be analysed interactively with the ability to
follow-up with participants [1–3]. Apart from understanding how to use new technology
and the expertise required to match the study design with data collection, adequate statisti-
cal software for data analysis and cleaning is mandatory [4,5]. Immediate technical support
and fluent communication between the administrators and participants is also crucial.
The high risk of mortality associated with general anaesthesia in horses remains one
of the biggest concerns for equine practitioners and veterinary anaesthetists. Many studies
report anaesthesia-related mortality risks. Most of these studies are retrospective [6–14]
but a few prospective single-centre [15] and some prospective, multi-centre [16,17] investi-
gations have been carried out. To date, the Confidential Enquiry into Perioperative Equine
Fatalities 2 (CEPEF2) published in 2002 remains the largest observational, multicentre study
with 41,824 cases collected from 62 clinics over a period of 6 years [18]. The overall death
rate up to seven days was 1.9%, 0.9% in noncolics and 7.8% in colics [18]. Although much
has changed since then, we are still far from reducing these numbers [19], and the need
for an update on the CEPEF data was proclaimed eight years ago [20]. Avoiding general
anaesthesia by undertaking some procedures in standing horses may reduce the mortality,
but there are no data as yet to support this hypothesis.
The first objective of this report was to describe the usefulness of an internet-based
method for data collection and a strategy for data cleaning for the CEPEF4 study, whose
final aim is to identify the risk factors associated with equine anaesthesia and standing
sedation. Second, to report the outcomes/fatalities within a period of seven days of equidae
undergoing (i) general anaesthesia and (ii) certain procedures performed under standing
sedation during the first six months of CEPEF4 and to describe the key preliminary findings
that will be analysed in detail in the future. Our first hypothesis was that the proposed
method would be a fast, reliable tool to collect, clean and analyse data. Second, that
mortality was lower than reported by Johnston et al. almost 20 years ago [18] and that
standing sedation procedures are not exempt from the risk of death, although it is reduced.
Finally, we hypothesised that there would be trends towards new practices in anaesthesia
and analgesia compared with the previous CEPEF2.
2. Materials and Methods
The study design was multicentre, cohort, observational, analytical, longitudinal and
prospective. For this phase of preliminary results, the six-month data collection period was
from 1 November 2020 until 30 April 2021.
Inclusion criteria comprised cases of horses, donkeys and mules of all ages from clinics
all over the world, recruited specifically for this project. The equidae involved were all cases
from each clinic undergoing (i) general anaesthesia whatever the reason and (ii) standing
sedation for surgery or advanced diagnostic imaging (magnetic resonance imaging (MRI),
computed tomography (CT) or scintigraphy) requiring a continuous rate infusion (CRI)
or at least one extra top-up apart from the initial sedation bolus. Once recording started
in any one clinic, all cases had to be included. However, to allow for holidays and staff
absence, all cases within a specified period could be omitted; recording and sending all
cases started again after the specified period.
Exclusion criteria were cases outside the agreed recording periods, cases from centres
that did not follow the communication process and cases from centres that did not send all the
cases from a recording period. General anaesthetics for terminal procedures were excluded,
as well as standing sedations without top-ups or CRIs, and standing sedations for reasons
other than surgery or advanced diagnostic imaging, such as cast changes or sinuscopies.
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The steps followed in this study are detailed below:
(1) Preparation of the questionnaire
A user-friendly, online questionnaire used in small animals [21] was adapted for this
equine study using the feedback received from a group of researchers and clinicians with
special interest in equine anaesthesia and analgesia [22]. It was designed to be used to
compile information for both general anaesthesia and standing sedation.
Briefly, the questionnaire collected data about the centre, the level of training of the
responsible anaesthetist, the patient, the procedure, the anaesthetic and analgesic protocols
and other details about management of the anaesthesia or sedation. Information about the
anaesthetic induction and recovery phases was included, with the potential to indicate any
intraoperative complications and details of the postoperative period for up to seven days.
The questionnaire and the instructions to complete it are available on a website created for
support and promotion at https://cepef4.wordpress.com (accessed on 6 June 2021), and
are provided here as Supplementary Materials S1.
(2) Definition of perioperative equine fatalities
The same classification of fatalities was followed as used in previous CEPEF stud-
ies [16,18]. After induction of general anaesthesia or the first sedation bolus for standing
sedation, the outcome was recorded at day seven for each case as (i) alive (or discharged),
(ii) put to sleep (PTS)/euthanised or (iii) dead. The time of PTS or dead was recorded as pre-
medication, induction, maintenance, recovery or the day up to day seven. Each centre was
encouraged to use an outcome logbook to communicate further which colic or noncolic
cases were alive, PTS or dead during this seven-day period.
When a horse was euthanized due to an inoperable lesion found at surgery, due to
pre-existing disease or financial constraints, the outcome was classified as PTS. When
a horse died unexpectedly or was euthanised due to a perioperative complication, such
as a fracture in recovery, the outcome was classified as death. Other examples of death
include intraoperative cardiac arrest, spinal cord malacia requiring euthanasia during
recovery or post-operative myopathy requiring euthanasia on humane grounds up to seven
days after surgery. Those classified as noncolic deaths were required to complete a more
detailed online survey at https://edinburgh.onlinesurveys.ac.uk/equine-ga-mortality-
form (accessed on 6 June 2021).
Classification of outcomes was performed by M.G.-M. and J.I.R., and later confirmed
by R.B.-W., M.J. and P.M.T. Ultimately, before final data analysis, the outcomes were
confirmed with the contact person from each centre, referred to as the ambassador (see (10)
in Methods).
(3) Ethics statement
The study was approved by the international Ethical Review Committee of the Asso-
ciation of Veterinary Anaesthetists (AVA), under protocol 2020-009 on 4 September 2020.
Full details of the application form were provided to any centre that also required Local
Ethical Committee Approval from their institution.
(4) Recruitment of collaborating centres
Recruitment included an abstract presented at the AVA Spring meeting in Dublin
2020 [23], and Correspondence to the Editor published in peer reviewed journals targeting
equine practitioners [24] and veterinary anaesthetists [22], respectively. Finally, we also
used our professional network and contacted several centres personally.
(5) The Ambassador figure and the Agreement Form
Ambassadors for each centre volunteered or were recruited to be the contact person
who also took responsibility for the centre’s data collection.
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Before sending the data, the ambassador signed an agreement form (https://cepef4
.wordpress.com/forms-instructions-and-help/ (accessed on 6 June 2021)) ensuring to cooper-
ate/supervise selflessly, providing good quality data including all the cases within a period of
time to avoid bias. The CEPEF team certified the anonymous handling of the data.
(6) Anonymity and confidentiality of each patient, owner and centre
As in previous CEPEF studies, the anonymity and confidentiality of the patients,
owners and centres was ensured. Identification of each patient was provided by a number
given by the centre for further communication with the CEPEF team. These numbers were
used only for communication with each centre. Each case entered in the database received
a unique CEPEF number for data handling and analysis. Moreover, each centre had a code
known only by M.G.-M. and J.I.R. The remaining authors, R.B.-W., J.I.R. and P.M.T., were
not aware of centre coding for further evaluation of the data.
(7) The communication process (recruitment and follow-up meetings)
We instituted a method of interactive communication with the ambassador of each
centre always performed by the same investigator (M.G.-M.) in order to standardize the
information and, therefore, reduce data inconsistencies. For each centre, the project was first
presented to the ambassador, and ideally, also to the whole team involved in data collection,
via an online meeting (Teams® (Microsoft Corporation, Redmond, WA, USA), Zoom®
(Zoom Video Communications Inc., San Jose, CA, USA), Skype® (Microsoft Corporation,
Redmond, WA, USA), Meet® (Google Inc., Mountain View, CA, USA)) of about one hour’s
duration. This included a standard presentation of the project, introduction to the study
website and explained the questionnaire and its technicalities. At least a second, and ideally
a third, follow-up meeting was subsequently organised to ensure complete familiarity with
the system.
(8) Data collection and storage
The electronic questionnaire was used to collect the data (Supplementary Materials S1).
A .pdf file was programmed using Adobe Acrobat Pro® (Adobe Inc., San Jose, CA, USA).
This .pdf file can be completed using the free app Adobe Acrobat Reader DC (Adobe Inc.,
San José, CA, USA), available for the different operating systems (Android® (Google Inc.,
Mountain View, CA, USA), IOS® (Apple, Cupertino, CA, USA), Windows® (Microsoft
Corporation, Redmond, WA, USA) and macOS® (Apple, Cupertino, CA, USA)). The
questionnaire can be completed on any internet-connected device, including mobile phones,
tablets, laptops or computers. Once completed, the questionnaire is sent by e-mail to a
specific e-mail account in which all the questionnaires are stored. The collected metadata is
converted to a .csv file that is added to the main database as a new case.
(9) Data cleaning and statistics
Data processing and statistical analyses were performed using R 4.1.0 [25]. Data
quality was improved using an initial data cleaning phase performed with specific scripts
searching for inconsistencies. R scripts were introduced to detect duplicated cases or blank
fields as non-available data (-NA-) in the studied variables. Other R scripts detected more
sophisticated inconsistencies using Boolean algebra, for instance, in general anaesthetics
coded as inhalation anaesthesia only (INH) but where an alpha2-agonist CRI was ticked, or
when an inhalant agent was ticked for a standing sedation procedure. In addition, further
R scripts were used to detect uncommon anaesthetic practices, such as induction with an
inhalant agent or when premedication was not administered. The full list of the R scripts
used in this study can be found in the Supplementary Materials S2.
The ambassador of any centre where data inconsistencies were detected was contacted
and sent an Excel® (Microsoft Corporation, Redmond, WA, USA) file by e-mail to confirm
whether the inconsistencies were real and to request revision if so. These detected incon-
sistencies were corrected manually within the database, only with the strict agreement of
the ambassador.
Animals 2021, 11, 2549 5 of 23
Once data were cleaned, a descriptive analysis was performed. Tables and figures
were created using the following R packages: table1 (v1.4.1) [26], ggplot2 (v3.3.3) [27] and
rnaturalearth (v0.1.0) [28]. Variables that followed a normal distribution are shown as mean
± standard deviation, whereas those non-normally distributed are shown as median [range].
(10) Final meeting with each ambassador to double-check data and outcomes
The individual database from each centre was sent to the ambassador of the centre
before the final meeting. This included all the cases sent up until 30 April 2021. A personal-
ized report for the centre was included for its approval. Data were always double-checked
by the principal investigator (M.G.-M.) and the ambassador for each centre during a sched-
uled online meeting of about 30 to 90 min, depending on the volume of the data and
potential inconsistencies. The ambassadors were asked for feedback and to grade the
project and the communication process between 0 (worse) to 10 (excellent). These meetings
occurred between Monday 17 May and Thursday 3 June 2021.
Figure 1 shows the flow diagram of the process.
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(11) Reporting the results
The STROBE-Vet guidelines, an extension of the STROBE (Strengthening the Reporting
of Observational Studies in Epidemiology) statement [29], as recommended for reporting
of observational studies in veterinary medicine (https://strobevet-statement.org, accessed on
6 June 2021), (Supplementary Materials S3) were followed in order to maximise reporting quality.
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3. Results
During the specified first six months, 69 centres from 20 countries in four continents
collaborated to collect data (Figure 2, Table 1). As a result of continuous recruitment, each
centre had a different starting date for data collection.
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Table 1. Countries of origin of the 69 collaborating centres classified per type of hospital/clinic and cases and percentage of





Clinicians Total Centres Cases
1 % Cases
Belgium 2 2 0 4 1906 21.78
United Kingdom 3 10 0 13 1670 19.08
Republic of Ireland 1 2 0 3 1068 12.20
France 0 6 0 6 1025 11.71
Australia 0 2 0 2 898 10.26
Switzerland 2 2 0 4 444 5.07
Spain 6 2 0 8 399 4.56
United States of America 3 0 0 3 327 3.74
Germany 1 0 0 1 162 1.85
The Netherlands 1 1 0 2 150 1.71
Canada 2 0 0 2 142 1.62
Italy 2 0 0 2 120 1.37
Austria 1 0 0 1 97 1.11
Japan 0 1 0 1 82 0.94
Argentina 1 1 0 2 55 0.63
Chile 1 0 0 1 48 0.55
Uruguay 1 1 1 3 46 0.53
Brazil 4 0 0 4 44 0.50
Colombia 3 0 1 4 35 0.40
Mexico 0 2 1 3 34 0.39
Total 34 32 3 69 8752 100
1 The total number of cases includes horses, donkeys and mules.
Figure 3 shows the flow diagram describing the cases included or excluded from the
current analysis. The data cleaning process detected 193 empty data fields and 1310 in-
consistencies. After a discussion with the ambassador of each centre, 50 inconsistencies
were redeemed, but were noted as unusual practices. Sixty two empty data fields and
1260 inconsistencies were corrected. For standing sedations, 131 durations were not found
in the records of the centres and were coded as missing data.
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After data cleaning, 8752 cases (8656 horses, 92 donkeys and 4 mules) were confirmed.
The median and range of cases received per day were 48 [1–146]. These preliminary results
contain horse information only as the sample size for donkeys and mules is too small at
this stage.
Of the 8656 horse cases, 6701 were general anaesthetics and 1955 were standing
sedations. Of these, only 39 cases were procedures in the field, 31 total intravenous
anaesthetics and 8 standing sedations. The demographic data for general anaesthetics and
standing sedation are shown in Table 2.
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Table 2. Demographic data by general anaesthesia or standing sedation and overall, in 8656 horses.





Sex Female 2699 817 3516
Male 4002 1138 5140
Age Neonate (≤1 month) 229 30 259
Foal (1–12 months) 1407 27 1434
Young (1–5 years) 2314 328 2642
Adult (5–14 years) 2029 1131 3160
Geriatric (>14 years) 722 439 1161
BCS Normal 5766 1585 7351
Thin 415 129 544
Fat 520 241 761
ASA I 3007 1200 4207
II 2354 666 3020
III 546 79 625
IV 470 9 479
V 324 1 325
Reason 1 Abdominal 218 61 279
Colic 917 6 923
Diagnostic 479 959 1438
ENT 377 138 515
Fracture 166 28 192
Orthopaedics 3346 138 3484
Urogenital 820 103 923
Miscellaneous 898 573 1471
Colic/noncolic
Noncolic surgery 5784 1949 7733
Colic surgery 917 6 923
Type of anaesthesia Standing sedation 0 1955 1955
Inhalatory 2282 0 2282
PIVA 3718 0 3718
TIVA 701 0 701
Duration * <1 h 2317 594 2911
1–2 h 2815 744 3559
2–3 h 1123 333 1456
>3 h 446 153 599
Use of locoregional techniques No 5602 1114 6716
Yes 1099 841 1940
Use of mechanical ventilation No 1870 1955 3825
Yes 4831 0 4831
Timetable Normal 5866 1918 7784
Out of hours 835 37 872
Scheduling Scheduled 5120 1817 6937
Non scheduled 380 80 460
Urgent 1201 58 1259
1 Horses could be anaesthetized/sedated for more than one reason. ASA, American Society of Anaesthesiologists; BCS, body condition
score; ENT, ear–nose–throat; PIVA, partial intravenous anaesthesia; TIVA, total intravenous anaesthesia. * 131 durations in standing
sedations were coded as missing data.
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3.1. Perioperative Equine Fatalitiess
Sixty six of the 6701 horses that underwent general anaesthesia were classified as
having died (1.0%) (confidence interval 95% (CI 95%): 0.76–1.25%). Of these, 35 (out of
5784) were classified as noncolic deaths (0.6%) (CI 95%: 0.42–0.84%) and 31 (out of 917)
as colic deaths (3.4%) (CI 95%: 2.3–4.8%). Four of the 1955 horses undergoing standing
sedation died (0.2%); all were noncolic surgeries (0.2%) (CI 95%: 0.06–0.52%).
Of the 6701 horses that underwent general anaesthesia, 329 were classified as PTS
(4.9%) (CI 95%: 4.4–5.5%): 76 of 5784 as noncolic PTS (1.3%) (CI 95%: 0.88–1.45%) and
253 of 917 as colic PTS (27.6%) (CI 95%: 25.0–31.0%). From the 1955 horses undergoing
standing sedation, 13 were PTS (0.7%) (CI 95%: 0.35–1.13%): 11 noncolic surgeries out of
1949 (0.6%) (CI 95%: 0.28–1.01%) and 2 out of 6 colic surgeries (33.3%) (CI 95%: 4.3–77.7%).
The outcomes at seven days post-anaesthesia or standing sedation are shown in Table 3.
Details of the deaths classified as noncolics are presented in Table 4. Table 5 indicates the time
of death or PTS of all the cases whether general anaesthesia or standing sedation was used.
Table 3. Data from 6701 equine anaesthetics and 1955 equine standing sedations recorded: reason for
anaesthesia/standing sedation and outcome at 7 days post-anaesthesia. Horses could be anesthetized
or sedated for more than a reason.
Alive Dead % Deaths PTS % PTS Total
General anaesthesia
Noncolic surgery 5673 35 0.6% 76 1.3% 5784
Abdominal 198 3 1.4% 17 7.8% 218
Diagnostic 440 3 0.6% 36 7.5% 479
ENT 373 4 1.1% 0 0.0% 377
Fracture 154 7 4.2% 4 2.4% 166
Miscellaneous 882 5 0.6% 11 1.2% 898
Orthopaedics 3306 13 0.4% 27 0.8% 3346
Urogenital 803 7 0.9% 10 1.2% 820
Colic surgery 633 31 3.4% 253 27.6% 917
Overall 6306 66 1.0% 329 4.9% 6701
Standing sedation
Noncolic surgery 1934 4 0.2% 11 0.6% 1949
Abdominal 59 1 1.6% 1 1.6% 61
Diagnostic 950 0 0.0% 9 0.9% 959
ENT 137 0 0.0% 1 0.7% 138
Fracture 27 1 3.6% 0 0.0% 28
Miscellaneous 570 1 0.2% 2 0.4% 573
Orthopaedics 138 0 0.0% 0 0.0% 138
Urogenital 100 1 1.0% 2 1.9% 103
Colic surgery 4 0 0.0% 2 33.3% 6
Overall 1938 4 0.2% 13 0.7% 1955
ENT, ear–nose–throat; PTS, “put to sleep” (euthanized) horses.
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Table 4. Noncolic deaths under general anaesthesia and standing sedations.
Pre-Existing Condition and Brief Noncolic Death Description n Phase Protocol
General anaesthesia
ASA I and II 18
Fracture in recovery (2 ASA I, 3 ASA II) 5 Recovery 2 PIVA, 2 INH, 1 TIVA
Post-operative colic (5 ASA II) 5 Days 3, 4, 5, 5 and 5 3 PIVA, 2 INH
Post-operative myelomalacia (2 ASA II) 2 Days 2 and 4 2 PIVA
Cardiac arrest (ASA I) 1 Maintenance INH
Upper airway obstruction in recovery (ASA II) 1 Recovery PIVA
Fracture C2 (ASA II) 1 Recovery PIVA
Sudden collapse after standing (ASA I) 1 Recovery TIVA
Presumed spinal cord malacia (ASA II) 1 Recovery PIVA
Small colon prolapse (ASA II) 1 Day 1 PIVA
ASA III, IV and V 17
Re-fractures in recovery (3 ASA IV) 3 Recovery 3 PIVA
Recumbent on arrival. Unable to stand after anaesthesia (2 ASA III) 2 Recovery 1 PIVA, 1 TIVA
Intraoperative bleeding without response to treatment (2 ASA III) 2 Maintenance 2 PIVA
Catastrophic recovery (<1 year with sling) (ASA III) 1 Recovery PIVA
Post-operative colic (1 ASA III) 1 Day 3 INH
Re-fracture olecranon in the stable (ASA III) 1 Day 3 PIVA
Unknown, could not stand, no fracture diagnosed in X-rays (ASA III) 1 Recovery INH
Severe chronic sinusitis. Sudden death. Necropsy: communication
between sinus fistula and cranial cavity (ASA IV)
1 Recovery TIVA
Foal with sepsis, diarrhoea (ASA IV) 1 Day 5 TIVA
Bladder rupture on caesarean section (ASA V)
Fracture rib repair, hemothorax and hemopericardium (ASA V)
1 Maintenance PIVA
1 Maintenance INH
Fracture/abductor tear after dystocia (ASA V)
Intraoperative bleeding dystocia (ASA V)
1 Day 2 PIVA
1 Day 1 INH
Standing sedation 4
Post-operative colitis (ASA I, ASA II) 2 Days 1 and 6 CRI
Post-operative colic (ASA III) 1 Day 2 CRI
Re-fracture in stable (ASA III) 1 Day 1 CRI
ASA, American Society of Anaesthesiologists; CRI, continuous rate infusion; INH, inhalational anaesthesia only; PIVA, partial intravenous
anaesthesia; TIVA, total intravenous anaesthesia.
Table 5. Time of death of horses under general anaesthesia and standing sedation.
PREM IND MAIN REC 1D 2D 3D 4D 5D 6D 7D
Colic Deaths 1 3 7 10 6 1 1 1 0 0 1
PTS 0 0 186 12 14 15 9 5 9 0 5
Noncolic Deaths 0 0 5 18 4 3 3 1 4 1 0
PTS 0 0 38 3 15 12 8 4 3 1 3
Total Deaths 1 3 12 28 10 4 4 2 4 1 1
PTS 0 0 224 15 29 27 17 9 12 1 8
IND, induction; MAIN, maintenance; PREM, premedication; REC, recovery period; PTS, “put to sleep” (eutha-
nized) horses. 1D–7D: days 1st to 7th.
3.2. General Anaesthesia
The centres sent a median of 100% of cases (100 [95–100]%). Of the 69 centres, 63 confirmed
that 100% of the cases were sent, three sent more than 98% and three sent more than 95%.
Table 6 gives the details of the individual drugs used at each phase of general anaesthesia.
The protocols for the general anaesthetics are described in Tables 7–11. Information about
the method of induction and recovery from general anaesthesia is shown in Tables 12 and 13,
respectively. Figure 4 describes the monitoring of the horses under general anaesthesia.
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Table 6. List of the individual drugs used at each phase of general anaesthesia in a total of 6701 horses.
Drugs PREM IND MAIN—(BolusIf Not Inhalant) MAIN-CRI POST
Acepromazine 2776 0 42 0 162
Xylazine 3231 0 327 724 2303
Detomidine 1569 0 44 274 340
Romifidine 1874 0 89 1132 1699
Medetomidine 236 0 81 471 287
Dexmedetomidine 5 0 65 296 52
Midazolam 87 2795 40 125 2
Diazepam 112 3293 17 0 2
Morphine 1270 0 239 7 222
Methadone 498 0 66 2 26
Pethidine 0 0 0 0 0
Fentanyl 6 0 4 3 0
Buprenorphine 2 0 1 0 5
Butorphanol 3320 0 261 238 94
Phenylbutazone 2647 0 64 0 657
Flunixin 2223 0 73 0 673
Meloxicam 413 0 5 0 143
Ketoprofen 93 0 1 0 6
Propofol 0 316 40 8 21
Alfaxalone 0 0 1 0 0
Ketamine 0 6633 1158 1090 37
Thiopental 0 95 234 0 23
TLT-ZLZ 0 41 1 0 0
GGE 0 84 44 442 0
Halothane 0 0 0 0 0
Isoflurane 0 1 5250 0 0
Sevoflurane 0 1 547 0 0
Desflurane 0 1 203 0 0
Lidocaine 17 0 0 1255 86
Dobutamine 0 0 0 4281 20
Phenylephrine 0 0 12 277 960
CRI, continuous rate infusion; GGE, guaiacol glyceryl ether; IND, induction; MAIN, maintenance; POST, immedi-
ate postoperative period; PREM, premedication; TLT-ZLZ, tiletamine-zolazepam.
Table 7. Drugs and different drug combinations used for premedication before general anaesthesia
in 6701 horses.
Drugs and Combinations n %
Alpha2 + Partial/Agonists-Antagonists Opioids 2214 33.0%
ACP + Alpha2 + Partial/Agonists-Antagonists Opioids 1026 15.3%
ACP + Alpha2 + Pure Opioids 1017 15.2%
Alpha2 alone 872 13.0%
ACP + Alpha2 721 10.8%
Alpha2 + Pure Opioids 704 10.5%
Partial/Agonist-Antagonist Opioid alone 62 0.9%
Pure Opioid alone 31 0.5%
Benzodiazepine alone 27 0.4%
ACP + Alpha2 + Pure Opioids + Partial/Agonists-Antagonists Opioids 11 0.2%
Alpha2 + Pure Opioids + Partial/Agonists-Antagonists Opioids 8 0.1%
ACP + Partial/Agonists-Antagonists Opioids 1 0.0%
None 7 0.1%
ACP, acepromazine; Alpha2, Alpha2-agonists. Benzodiazepines: 199 − 27 = 172 were used in different combina-
tions but not alone.
Animals 2021, 11, 2549 12 of 23
Table 8. Drugs used for induction of general anaesthesia in 6701 horses.
Induction Drugs n %
Ketamine + Benzodiazepine 5919 88.3%
Ketamine + Propofol 295 4.4%
Ketamine alone 247 3.7%
Ketamine + Thiopental 91 1.4%
Ketamine + GGE 80 1.2%
Tiletamine + Zolazepam 41 0.6%
Propofol 21 0.3%
Thiopental + GGE 3 0.1%
Ketamine + Inhalatory 1 0.0%
Inhalatory + GGE 1 0.0%
Thiopental alone 1 0.0%
Inhalatory 1 0.0%
GGE, guaiacol glyceryl ether. Benzodiazepines: 6088 − 5919 = 169 were used in different combinations but
benzodiazepines + ketamine.
Table 9. Drugs used for maintenance of general anaesthesia in 6701 horses.
Maintenance Drugs n %
Isoflurane 5250 78.3%
Sevoflurane 547 8.2%
Triple drip alone 277 4.1%
Desflurane 203 3.0%
Ketamine alone 87 1.3%
Thiopental alone 4 0.1%
Ketamine + Thiopental 3 0.0%
None 330 5.0%
Table 10. Drugs used for continuous rate infusion during general anaesthesia with partial intravenous
anaesthesia (PIVA) in 3718 horses.
CRI Drugs n %
Alpha2 alone 1780 47.9%
Lidocaine alone 1041 28.0%
Alpha2 + Ketamine 384 10.3%
Alpha2 + Ketamine + Butorphanol 147 4.0%
Alpha2 + Lidocaine 78 2.1%
Ketamine alone 70 1.9%
Alpha2 + Butorphanol 68 1.8%
Lidocaine + Ketamine 65 1.7%
Alpha2 + Lidocaine + Ketamine 47 1.3%
Alpha2 + Lidocaine + Butorphanol 18 0.5%
Other combinations 20 0.5%
Alpha2, Alpha2 agonists; CRI, continuous rate infusion.
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Table 11. Parenteral drugs administered for/during the immediate recovery period after general
anaesthesia in 6701 horses.
Drugs and Combinations n %
Alpha2 alone 4220 63.0%
Alpha2 + Pure Opioids 197 2.9%
ACP + Alpha2 91 1.4%
Alpha2 + Partial/Agonists-Antagonists Opioids 65 1.0%
ACP alone 38 0.6%
Pure Opioid alone 37 0.6%
ACP + Alpha2 + Partial/Agonists-Antagonists Opioids 18 0.3%
Partial/Agonist-Antagonist Opioid alone 11 0.2%
ACP + Alpha2 + Pure Opioids 10 0.1%
ACP + Partial/Agonists-Antagonists Opioids 3 0.0%
Benzodiazepine alone 2 0.0%
ACP + Alpha2 + Pure Opioids + Partial/Agonists-Antagonists Opioids 1 0.0%
ACP + Pure Opioids 1 0.0%
Pure Opioids + Partial/Agonists-Antagonists Opioids 1 0.0%
None 2006 29.9%
ACP, acepromazine; Alpha2, Alpha2 agonists. Alpha2-agonists: 79 cases received more than one alpha2-agonist in
the recovery.
Table 12. Methods of induction of general anaesthesia for 6701 horses under inhalational anaesthesia
only (INH), partial intravenous anaesthesia (PIVA), total intravenous anaesthesia (TIVA) and overall.







Personnel assisted 1498 (65.6%) 2010 (54.1%) 570 (81.3%) 4078 (60.8%)
Gate 353 (15.5%) 1207 (32.5%) 86 (12.3%) 1646 (24.6%)
Free 407 (17.8%) 479 (12.9%) 44 (6.3%) 930 (13.9%)
Table 18 (0.8%) 9 (0.2%) 0 (0%) 27 (0.4%)
Sling 6 (0.3%) 13 (0.3%) 1 (0.1%) 20 (0.3%)
Table 13. Methods of recovery from general anaesthesia for 6461 horses after inhalational anaesthesia









Free 1049 (47.2%) 1770 (50.0%) 462 (66.7%) 3281 (50.8%)
Ropes 942 (42.3%) 1598 (45.1%) 116 (16.7%) 2656 (41.1%)
Manual 234 (10.5%) 175 (4.9%) 115 (16.6%) 524 (8.1%)
* 6701 − 6461 = 240 horses that were put to sleep (PTS) or died before recovery (i.e., premedication, induction
or maintenance).






Figure 4. Percentage of monitoring used in 6701 horses undergoing general anaesthesia. ABG, arterial blood gases; ECG,
electrocardiogram; EtCO2, end-tidal carbon dioxide; FiO2, inspiratory fraction of oxygen; IBP, invasive blood pressure; NIBP,
non-invasive blood pressure; SpO2, partial saturation of haemoglobin with oxygen by pulse-oximetry; TEMP, temperature;
VOLATILE AG., volatile agents measured for inspired fraction and end-tidal concentration.
3.3. Standing Sedation
From the 69 collaborating centres, 57 sent standing sedation cases that fulfilled our
inclusion criteria (median 99 [10–100]%). Forty-three centres sent more than 90% of their cases,
four sent between 80 and 90%, five sent between 50 and 80% and five sent between 1 and 49%.
The drugs and protocols for standing sedations are shown in Tables 14 and 15, respec-
tively. Table 16 reports the different CRIs used to maintain standing sedation. Figure 5
describes the monitoring of the horses under sedation.
Table 14. Drugs used for standing sedation in 1955 horses.
Drugs PREM MAIN—(Bolus) MAIN-CRI POST
Acepromazine 918 15 0 1
Xylazine 61 17 29 1
Detomidine 1574 1178 525 1
Romifidine 405 302 60 0
Medetomidine 11 8 10 0
Dexmedetomidine 4 7 4 0
Midazolam 15 61 34 0
Diazepam 3 10 1 0
Morphine 532 54 76 7
Methadone 223 20 4 2
Pethidine 2 0 0 0
Fentanyl 2 0 0 0
Buprenorphine 3 0 0 0
Butorphanol 922 437 94 0
Phenylbutazone 253 5 0 115
Flunixin 513 3 0 137
Meloxicam 39 2 0 14
Ketamine 0 8 24 0
Phenylephrine 0 1 3 14
CRI, continuous rate infusion; MAIN, maintenance; POST, postoperative period; PREM, premedication.
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Table 15. Drugs and different drug combinations used for premedication before standing sedations
in 1955 horses.
Drugs and Combinations n %
Alpha2 + Partial/Agonists-Antagonists Opioids 588 30.1%
ACP + Alpha2 + Pure Opioids 393 20.1%
Alpha2 + Pure Opioids 338 17.3%
ACP + Alpha2 + Partial/Agonists-Antagonists Opioids 312 16.0%
ACP + Alpha2 203 10.4%
Alpha2 alone 93 4.8%
Alpha2 + Pure Opioids + Partial/Agonists-Antagonists Opioids 14 0.7%
ACP + Alpha2 + Pure Opioids + Partial/Agonists-Antagonists Opioids 10 0.5%
Pure Opioid alone 3 0.1%
Partial/Agonist-Antagonist Opioid alone 1 0.0%
ACP, acepromazine; Alpha2, Alpha2 agonists.
Table 16. Drugs and different drug combinations used for continuous rate infusion in standing
sedations in 1955 horses.
CRI Drugs n %
Alpha2 alone 448 22.9%
Alpha2 + Butorphanol 88 4.5%
Alpha2 + Morphine 66 3.4%
Alpha2 + Ketamine 10 0.5%
Alpha2 + Ketamine + Morphine 8 0.4%
Alpha2 + Ketamine + Butorphanol 4 0.2%
Alpha2 + Methadone 3 0.2%
Other combinations 6 0.3%
No CRI (only top-ups) 1322 67.6%






Figure 5. Percentage of monitoring used in 1955 horses undergoing standing sedation. ABG, arterial blood gases; ECG,
electrocardiogram; EtCO2, end-tidal carbon dioxide; FiO2, inspiratory fraction of oxygen; IBP, invasive blood pressure; NIBP,
non-invasive blood pressure; SpO2, partial saturation of haemoglobin with oxygen by pulse-oximetry; TEMP, temperature;
VOLATILE AG., volatile agents measured for inspired fraction and end-tidal concentration.
3.4. Results of Survey for Feedback in Final Meeting
The ambassadors of the collaborating centres gave a final mark for the project and the
communication process of median 10 [7–10] (0—worse to 10—excellent).
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4. Discussion
The results presented here demonstrate the utility of the electronic questionnaire and
the internet-based method for data collection, with interactive data handling and cleaning
for the performance of the CEPEF4 study. The data collected from the 1 November 2020
until the 30 April 2021 show that overall, 1% of horses undergoing general anaesthesia
still die within the seven-day outcome period. Even with this preliminary evaluation of a
small number of horses, it appears that a fatal outcome in both noncolics (0.6%) and colics
(3.4%) was less frequent than that reported by Johnston et al. almost 20 years ago [18]. As
anticipated, and despite the higher risk of bias collecting standing sedation data, the risk of
death with standing sedation (0.2%) appears lower than with general anaesthesia. However,
even with a lower risk, some noncolic horses died unexpectedly when undergoing standing
sedation within the seven-day outcome period. The data also demonstrate certain changes
in the routine anaesthetic practice and protocols that have developed since CEPEF2.
In light of our findings, and focussing on our main objectives, the discussion is
structured in the following four parts: (1) the proposed method for data collection with
interactive data handling and cleaning, (2) the outcomes of horses that underwent general
anaesthesia and standing sedation, (3) the preliminary data from horses undergoing general
anaesthesia and (4) the preliminary results of standing sedation in horses.
(1) The proposed method for data collection with interactive data handling and cleaning
Our first hypothesis was confirmed as the proposed internet-based method proved to
be a reliable, easy, quick and cheap means of collecting data, with minimal geographical
limitations. This preliminary phase of CEPEF4 was initiated and executed during the COVID-
19 pandemic but our methodology allowed us to communicate with the collaborating centres
and to collect and handle data arising from many locations worldwide. The feedback from the
ambassadors of each centre indicated that the communication process (recruitment, follow-
up and final meetings) allowed fluent communication that undoubtedly contributed to the
collection of good quality data [2]. Once collected, our R scripts detected many inconsistences
that were reduced almost to zero prior to final submission. The three steps followed for this
data cleaning proved effective: first, data screening to detect missing or excess data, outliers,
inconsistencies or strange patterns. Second, diagnosis to detect missing data, true extremes
or true errors. Finally, data editing or treatment to correct, delete or leave unchanged the
detected inconsistencies [5] as agreed with each centre’s ambassadors. Even with this large
dataset, we achieved a reliable method with a clear strategy for communication and data
collection/cleaning. This approach will help to minimize inconsistencies that might lead to
data misinterpretation for the current CEPEF4 study.
For the first six months, we compiled 8656 horse cases: 6701 general anaesthetics and
1955 standing sedations. CEPEF1 collected 6255 general anaesthetics in a period of two
years (February 1991–March 1993), using paper copies and communication by post and
telephone [16]. This reflects the importance of new technologies that allow interactive
communication, data collection and analysis. Furthermore, the rapid availability of a
community of researchers and equine clinicians familiar with the CEPEF studies made this
work possible in such a short period of time. The impact of the CEPEF2 study, cited by
448 other publications (according to Google Scholar on the 29 August 2021), reflects the
importance of an update on these data [20].
With the first hypothesis confirmed, our final goal is to use this methodology to collect
approximately 45,000 cases of general anaesthetics for CEPEF4, to increase the statistical
power and to compare the results with those of 20 years ago [18]. In order to ensure a robust
comparison, we followed the same approach as in CEPEF2. Both M.J. and P.M.T., authors of
the previous series, carefully supervised the study design and the subsequent implementation
of data collection and cleaning. On the basis of the cumulative cases collected per week to
date, the proposed cases numbers should be reached in approximately two years.
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(2) Outcome of horses under general anaesthesia and standing sedation
As reported in CEPEF2 [18], the overall equine anaesthetic mortality rate is still higher
than in other veterinary species such as dogs and cats [30]. However, these preliminary
data from a small population do suggest that the current rate is lower than 20 years ago.
As stated in 2016 by Dugdale and Taylor [19], “we still lose horses after anaesthesia to a
range of catastrophes that would not occur if the horse were not anaesthetized”. Our preliminary
results confirm this statement. We recorded 39 horses that were classified as noncolic
deaths: 34 general anaesthetics, four standing sedations and one that started as standing
sedation and later changed to general anaesthesia.
Focusing on the noncolics undergoing general anaesthesia, with the exception of
17 cases classified as moderate- or high-risk patients (ASA III, IV or V), the remaining
18 were healthy (four ASA I, 14 ASA II). This indicates that noncolic horses undergoing
general anaesthesia still die unexpectedly; 0.6% at this stage, versus the 0.9% of CEPEF2.
Further recruitment of cases to achieve our final CEPEF4 goal should help to clarify why
this occurs and hopefully suggest how these numbers could be reduced.
With regard to colics undergoing general anaesthesia, our preliminary data recorded
3.4% that died, compared to the 7.8% (457 colic deaths out of 5846) in CEPEF2. This relative
reduction may indicate an improvement in the peri-operative management of horses with
colic. However, the number of colic PTSs remain extremely high, 27.6% in this data versus
the 25.2% of CEPEF2.
It is generally assumed that standing procedures are safer than general anaesthesia in
horses. However, this is the first study to report mortality rates associated with standing
sedation in a multicentre, prospective, cohort study. The four standing sedations (one ASA
I, one ASA II and two ASA III) classified as noncolic deaths (0.2%) provide evidence that
standing sedation procedures still carry a risk, albeit less than general anaesthesia.
(3) Preliminary results for general anaesthetics in horses
One third of the horses were premedicated with a combination of an alpha2-agonist
and a partial/agonist-antagonist opioid, mainly butorphanol. When acepromazine was
also given, the percentage increased to 48%. Alpha2-agonists with a pure opioid, with or
without acepromazine, was used in about 26% of the cases. Only 13% of the cases received
an alpha2-agonist alone. This is in contrast with the CEPEF2 data, in which 43% of the
horses received an alpha2-agonist alone, 29% combined acepromazine with an alpha2-
agonist and no more than 8% included opioids such us methadone or butorphanol [18].
Our data show the tendency for premedication with drug combinations rather than a
single agent. Drug combinations calm the horse, enhance sedation and provide analgesia
by employing low doses of each drug, which reduces their potential side effects [31–33].
Compared with around 16% in CEPEF2 [18], premedication with acepromazine alone has
not been reported in the current study.
Ketamine was the most commonly used intravenous agent for the induction of general
anaesthesia, usually combined with a benzodiazepine as a central muscle relaxant (88%).
Diazepam was frequently used, and increasingly midazolam, which was not reported at
all in CEPEF2. Midazolam has recently gained Market Authorisation for use in horses in
Europe, which would support its increased use. Thiopental and guaiphenesin, an intravenous
anaesthetic and a central muscle relaxant, respectively, were rarely used. This combination
was historically the evolution from chloral hydrate and pentobarbital [34]; however, the
often prolonged and violent recovery from barbiturate anaesthesia provoked the transition
towards ketamine [35]. A few techniques were popular in some individual clinics, although
the overall numbers were not high. For example, the induction and brief maintenance of
general anaesthesia in foals with propofol, sometimes combined with ketamine [36].
Isoflurane was the most common inhalation agent used for the maintenance of general
anaesthesia (88%), followed by sevoflurane (9%) and desflurane (3%). None of the anaes-
thetics reported in these preliminary results used halothane in contrast with the previous
CEPEF studies [16,18]. In 2004, halothane was considered an acceptable anaesthetic for
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the maintenance of anaesthesia in horses [37]; however, it is no longer manufactured and
is now rarely used. Our data also showed the current tendency to use an inhalant agent
in combination with an intravenous CRI, the so-called partial intravenous anaesthesia
(PIVA) [38–40]. Out of all the 6000 inhalant-based general anaesthetics, 3718 were PIVA
(62%) versus 2282 (38%) that were pure inhalation anaesthesia. Since the publication of
CEPEF2 nearly 20 years ago, there have been numerous reports of PIVA techniques using
alpha2-adrenergic agonists [41,42], lidocaine [43], ketamine [44] and opioids [45,46].
Only 701 of the total 6701 were general anaesthetics where total intravenous anaesthe-
sia (TIVA) was used, 31 under field conditions. Very short procedures were carried out in
the anaesthetic recovery box or in the field using repeated boluses of a range of drugs and
combinations. Ketamine, thiopental, alpha2-agonists and benzodiazepines were all used.
Less than 300 of the 701 TIVA cases were maintained with various combinations of the
so-called “triple drip”, usually combining ketamine with an alpha2-agonist and guaiphen-
esin [40]. The maintenance of anaesthesia for short procedures was also carried out with
ketamine alone or occasionally with thiopental.
Our data show that it is now common practice (63%) to administer a small dose of an
alpha2-agonist after the end of general anaesthesia before the recovery phase, either when
the patient is still on the surgical table and before transport to the recovery box, or once in
the recovery box. Santos et al. (2003) [47] first demonstrated its benefits, later confirmed
by others [48,49].
This study collected relevant information about the monitoring undertaken during
general anaesthesia. Although it has been recently suggested that improvements in mon-
itoring have reduced the risk of anaesthetic mortality [19], no data from a prospective,
multicentre study support this statement. Our data indicated that around 90% of the horses
undergoing general anaesthesia (INH, PIVA or TIVA) had an electrocardiogram and a pulse
oximeter. Arterial blood pressure (invasively) and the end-tidal carbon dioxide (EtCO2)
concentration were measured in more than 75%. Inspired oxygen and an end tidal volatile
agent were measured in fewer cases, but still more than 50%. Arterial blood gas analyses
(70%) and lactate (43%) were performed most often in horses with colic. In general, body
temperature was not frequently monitored (33%), and the use of spirometry in horses was
minimal. Non-invasive blood pressure was sometimes used in foals, when an arterial line
had not been placed, or even with invasive blood pressure. These data are similar to those
reported via the online questionnaire in 2015 by Wohlfender et al. [50].
The data show the current protocols for the induction of anaesthesia were usually
assisted, with either personnel (61%) or using a gate (25%). For recovery, 51% were free,
41% were assisted with ropes and 8% were manually assisted, mostly foals. These data
reflect the ongoing controversy about which is the best method of recovery from general
anaesthesia. Head and tail rope systems do not completely prevent fractures during
recovery [51–53], but some cases may benefit from this technique. Slings were used in
some cases but again did not ensure a good recovery: one young horse became excited
with sling assistance and recovered badly after an elbow fracture repair; this was one of
the unexpected noncolic deaths.
(4) Preliminary results of standing sedations in horses
The data presented here are the first reported from a prospective, multicentre, cohort
study of standing sedation, but the numbers are small and cautious interpretation is still
in order.
Whereas the data collected from general anaesthetics can be considered as strong
and reliable, only 43 of the 57 centres sent more than 90% of their standing sedation cases,
which could lead to biased data. The main challenge for centres with a high case load was
to collect every single case.
Alpha2-agonists were used in all except three of the premedication combinations.
Acepromazine was not given alone but, combined with at least an alpha2-agonist, it was
given to 47% of the cases. Opioids, mostly butorphanol, morphine and methadone were
used in 85% of the cases. Boluses of detomidine, butorphanol and romifidine are the most
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commonly used for the maintenance of standing sedations. For CRIs, detomidine was the
most commonly used, followed by far, by butorphanol. Monitoring in standing sedation
procedures was minimal.
Many of the procedures previously performed only in anaesthetised horses are now
carried out using standing sedation. Although the inclusion criteria were more restrictive
and not all the centres were able to supply these procedures, 23% of the cases in this study
were standing sedations. Further study of these data is required. Creating a subgroup of
collaborating centres may ensure more reliable data.
(5) Limitations
Our study is not free of limitations. First, the electronic questionnaire. Its use required
a learning curve and sometimes raised technological difficulties, all solved with online
support. The potential for creating a specific app is under consideration; however, the
adaptation to different software can be challenging. Second, the current version of the
questionnaire could be improved. For instance, the field “castrated” and “pregnant” is not
mandatory in the current version and could lead to misinterpretation. Drugs commonly
used, such as mepivacaine, were not included (but could be added manually). An updated
version will be created in response to the feedback from the collaborating centres. Third,
there is an inherent bias as some areas of the world and types of practice are underrep-
resented. Further strategies are to be implemented in this respect, although language
barriers should not be underestimated. Finally, the amount of information collected by the
questionnaire is enormous and cannot be covered in a single scientific paper. However,
and as stated in the agreement form, “sub-studies can be proposed, as long as this does not
involve duplicate use of the CEPEF4 data”. This may allow our community to benefit from our
method for collecting multicentric data for purposes other than mortality up to seven days.
5. Conclusions
We have designed a reliable method, with a clear strategy of communication and data
collection/cleaning that can be used to collect cases for CEPEF4. This approach will help to
minimize inconsistencies that may lead to data misinterpretation in future CEPEF studies.
This preliminary report shows that horses still die unexpectedly during and within the
seven-day postoperative period of general anaesthesia and standing sedation. Our results
also show that current practice in anaesthesia has changed over the last 20 years.
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Appendix A
List of the collaborating centres and ambassadors per country, ordered alphabetically
by country:
− Argentina: Centro de Cirugía Equina Santa Fe, Santa Fe (Natalia Rossetti); Hospital Escuela
de Grandes Animales FCV UNNE, Corrientes (Eduardo Darío Saravia)
− Australia: Goulburn Valley Equine Hospital, Congupna, Victoria (Valentina Di Sevo);
Scone Equine Hospital, Scone, New South Wales (Maria Helena Bellei)
− Austria: Veterinärmedizinische Universität Wien, Wien (Natalí Verdier)
− Belgium: Dierenkliniek de Bosdreef, Moerbeke-Waas, Oost-Vlaanderen (Katherine
Bafort and Hans Wilderjans); Equitom Equine Clinic, Meldert, Limbürg (Jamien
Deman and Tom Marien); Université de Liège, Liège, Wallonie (Julien Dupont and
Charlotte Sandersen); Universiteit Gent, Merelbeke, Oost-Vlaanderen (Stijn Schau-
vliege and Frank Gasthuys)
− Brasil: Universidade Federal de Minas Gerais, Belo Horizonte, MG (Suzane Lilian
Beier); Universidade Federal do Paraná, Curitiba, PR (Juan Carlos Duque Moreno);
Universidade de São Paulo, Pirassununga, SP (Adriano Carregaro); Universidade de
São Paulo, São Paulo, SP (Denise Tabacchi Fantoni)
− Canada: Université de Montréal, Saint Hyacinthe, Québec (Mathilde Ducroq, Javier
Benito de la Víbora and Paulo Steagall); Western College of Veterinary Medicine,
University of Saskatchewam, Saskatchewam (Barbara Ambros)
− Chile: HCV Universidad Nacional Andrés Bello, Santiago de Chile, Región Metropoli-
tana (Karina Aros Villarroel)
− Colombia: Gustavo Villa Díaz (ambulatory clinician), Medellín, Antioquia; Universi-
dad CES, Medellín, Antioquia (Gustavo Villa Díaz); Universidad Lasallista, Caldas,
Antioquia (Gustavo Villa Díaz); Universidad Tecnológica de Pereira, Pereira, Risaralda
(David Latorre Galeano)
− France: Centre Hospitalier Vétérinaire Équin de Livet, Calvados (Valerie Picanvet); Clin-
ique de Grosbois, Boissy Saint Leger, Val de Marne (Valerie Deniau); Clinique Équine
Acy Romance, Acy Romance, Grand Est (Justine Dalla Valle and Anneleen Michielsen);
Clinique Équine de la Boisrie, Chaylloue, Orne (Peggy Moreau); Clinique Équine de
Meslay, Pays de Loire (Bienvenida Román Durá and Tamara de Beauregard); Clinique
Vétérinaire Équine de Meheudin, Écouche, Orne (Elsa Autard and Florence Polle)
− Germany: TIHO Hannover, Hannover, Niedersachsen (Lara Twele, Álvaro Gutiérrez
Bautista and Sabine Kästner)
− Italy: Università di Bologna, Bologna (Carlotta Lambertini and Noemi Romagnoli);
Università di Perugia, Perugia (Sara Nannarone)
− Japan: Shadai Horse Clinic, Hokkaido (Tsukasa Suzuki)
− Mexico: Central Quirúrgica para Caballos, Naucalpan, Estado de México (Jorge Ed-
uardo Mendoza Flores); EQCOVET, Zapopan, Jalisco (Edgardo Hernández Díaz); Jorge
Eduardo Mendoza Flores (ambulatory clinician), Ciudad de México, Estado de México
− Republic of Ireland: Fethard Equine Hospital, Clonmel, Tipperary (Erica Sogus);
Somerton Equine Hospital, Friarstown, Kildare (Monica McNichol and Valerie Hyde);
University College Dublin, Dublin, Dublin (Vilhelmiina Huuskonen)
− Spain: Hospital de Referencia La Equina, Manilva, Málaga (Joana Maia Ramos, Maya
Caparrós Buscarons and Miguel Valdés Vázquez); Hospital Veteriario Costa de La
Luz, Conil de la Frontera, Cádiz (Ana del Ojo Morales); Universidad Alfonso X
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El Sabio, Villanueva de la Cañada, Madrid (Rocío Cañellas Blanco and Verónica
Salazar Nussio); Universidad Autónoma de Barcelona, Barcelona (Lucas Troya Portillo
and Cristina Costa Farré); Universidad Cardenal Herrera CEU, Valencia (Eva Zoe
Hernández Magaña, Jaime Viscasillas Monteagudo and José Ignacio Redondo García);
Universidad de Córdoba, Córdoba (Esther Caravaca Paredes and María del Mar
Granados Machuca); Universidad Complutense de Madrid, Madrid (Marta Villalba
Díez, Isabel Santiago Llorente and Ignacio Álvarez Gómez de Segura); Universidad
de Murcia, Murcia (Eliseo Belda Mellado and Francisco Ginés Laredo Álvarez)
− Switzerland: Bern Universität, Bern (Ilaria Petruccione and Olivier Levionnois); Pfer-
deklinik Dalchenhof, Brittnau, Aargau (Orquidea Kiesse); Pferdeklinik Niederlenz,
Niederlenz, Lenzburg (Theo Tschanz); Vetsuisse Faculty, University of Zürich, Zürich
(Simone Katja Ringer and Regula Bettschart-Wolfensberger)
− The Netherlands: Dierenhospital Visdonk, Roosendaal (Els van den Berg); Univer-
siteit Utrecht, Utrecht (Janny de Grauw and Thijs van Loon)
− United Kingdom: Ashbrook Equine Hospital, Allostock, Cheshire (Julia Shrubb); Bell
Equine Veterinary Clinic, Mereworth, Kent (Heloïse Lesca and Karen Coumbe); Bour-
ton Vale Equine Clinic, Cheltenham, Gloucestershire (Lydia Coles); Hird & Partners,
Shelf, West Yorkshire (John Hird); Liphook Equine Hospital, Liphook, Hampshire
(Rachel Tucker); Pool House Equine Clinic, Fradley, Staffordshire (Federica Cantatore,
Cristina Bertone and Sophie Malorey); Rainbow Equine Hospital, Malton, North York-
shire (Kate Loomes); Rossdales Ltd., Newmarket, Suffolk (Luis Louro and Catriona
McKenzie); Royal Veterinary College, Hatfield, Hertfordshire (Kata Veres-Nyeki);
The Donkey Sanctuary, Sidmouth, Devon (Abigail Sefton, Dom Doyle and Rebekah
Sullivan); The Universisty of Edinburgh, Easter Bush Campus, Midlothian (Chiara
Pressanto, Tom Beeston and Miguel Gozalo-Marcilla); University of Glasgow, Bears-
den, Glasgow (Josephine Kropf and Andrew Bell); Wright and Morten, Somerford,
Cheshire (Nicola Harries and Rachel Helm)
− United States of America: Colorado State University, Fort Collins, CO (Rachel Hec-
tor and Marlis Rezende); University of Missouri, Columbia, MO (Kelley Varner);
University of Pennsilvania—New Bolton Centre, Kennett Square, PA (Klaus Hopster)
− Uruguay: Facultad de Veterinaria—UDELAR, Montevideo (Sabrina Castro Peri,
Gastón Pérez and Camila Nan); María Noel Acevedo (ambulatory clinician), Montev-
ideo; Servicio de Veterinaria y Remonta, Canelones (Sabrina Castro Peri and María
Noel Acevedo)
Also, we would like to thank our colleagues that provided us the contacts of clinics in
the following countries/continents:
− Belgium (Stijn Schauvliege)
− France (Latifa Khenissi and Stijn Schauvliege)
− Japan (Paulo Steagall)
− México (José Antonio Ibancovichi)
− South America (Adriano Carregaro and Natalia Rossetti)
− The Netherlands (Janny de Grauw)
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